These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Exercise-induced ST segment elevation in leads V1 to V3 due to proximal right coronary artery stenosis. Wijeysundera HC; Bentley-Taylor M; Cohen E; Dick AJ Can J Cardiol; 2005 Aug; 21(10):875-6. PubMed ID: 16107911 [No Abstract] [Full Text] [Related]
5. Progressive subclavian artery stenosis causing late coronary artery bypass graft failure as a result of coronary-subclavian artery steal. Liava'a M; Theodore S; Brown R; Luthra S; Tatoulis J J Thorac Cardiovasc Surg; 2008 Feb; 135(2):438-9. PubMed ID: 18242285 [No Abstract] [Full Text] [Related]
6. Mitral valve endocarditis resulting from coagulase-negative Staphylococcus after stent implantation in a saphenous vein graft. Palmer ND; Ramsdale DR Cardiol Rev; 2005; 13(3):152-4. PubMed ID: 15831150 [TBL] [Abstract][Full Text] [Related]
7. Use of enoxaparin in a patient with unstable angina. Wang JC; Goldhaber SZ; Popma JJ J Invasive Cardiol; 2000; 12 Suppl C():18C-20C. PubMed ID: 10762864 [No Abstract] [Full Text] [Related]
8. Treatment synergy of silicon carbide-coated stenting and abciximab for complex coronary artery lesions: clinical results of a single-center study. van der Vleuten PA; Wijpkema JS; van den Heuvel AF; Bosma CA; Jessurun GA; Tio RA Ital Heart J; 2004 Sep; 5(9):663-6. PubMed ID: 15568593 [TBL] [Abstract][Full Text] [Related]
9. Importance of creativity: new applications of the Proxis catheter. Satler LF Catheter Cardiovasc Interv; 2009 Sep; 74(3):446-7. PubMed ID: 19681123 [No Abstract] [Full Text] [Related]
10. Low-molecular-weight heparin and abciximab for thrombo-occlusive saphenous vein graft disease. Report of 2 cases. Yaryura R; Doucet J; Mathur VS Tex Heart Inst J; 1997; 24(4):379-83. PubMed ID: 9456497 [TBL] [Abstract][Full Text] [Related]
12. Inadvertent dilation of a saphenous vein graft stenosis by the PercuSurge GuardWire distal protection balloon. Sharma N; Kalaria VG Catheter Cardiovasc Interv; 2003 Jul; 59(3):346-9. PubMed ID: 12822155 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous intervention on the LIMA: tackling the tortuosity. Sharma S; Makkar RM J Invasive Cardiol; 2003 Jun; 15(6):359-62. PubMed ID: 12777679 [TBL] [Abstract][Full Text] [Related]
14. [Use of a combination of enoxaparin or unfractionated heparin and abciximab during percutaneous coronary interventions: a randomized pilot study]. Galeote G; Hussein M; Sobrino N; Calvo L; Sánchez-Recalde A; Sobrino JA Rev Esp Cardiol; 2002 Dec; 55(12):1261-6. PubMed ID: 12459075 [TBL] [Abstract][Full Text] [Related]
15. The return of the left internal mammary artery after 11 years. Leong T; Unterseeh T Ann Thorac Surg; 2012 Sep; 94(3):e79. PubMed ID: 22916787 [No Abstract] [Full Text] [Related]
16. Use of low-molecular-weight heparin in percutaneous intervention. Curran MJ; Grines CL J Invasive Cardiol; 2000; 12 Suppl C():13C-17C. PubMed ID: 10762863 [No Abstract] [Full Text] [Related]
17. 30-year patency of a saphenous vein graft in coronary bypass graft surgery. Ozcan AV; Evrengul H; Goksin I; Gur S; Kaftan A Ann Thorac Surg; 2008 Apr; 85(4):e23. PubMed ID: 18355484 [No Abstract] [Full Text] [Related]
18. Direct coronary stenting through left and right internal mammary artery grafts. Bouki KP; van Haagen E; Bonnier H J Invasive Cardiol; 2002 Jul; 14(7):417-9. PubMed ID: 12082197 [TBL] [Abstract][Full Text] [Related]
19. Recruitable patency of the internal mammary artery graft. Villareal RP; Mathur VS Catheter Cardiovasc Interv; 2001 Jan; 52(1):95-9. PubMed ID: 11146533 [TBL] [Abstract][Full Text] [Related]
20. Surgeons and interventional cardiologists in a collaborative environment. Colombo A; Latib A J Am Coll Cardiol; 2009 Jan; 53(3):242-3. PubMed ID: 19147040 [No Abstract] [Full Text] [Related] [Next] [New Search]